Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study.
Izquierdo JL, Almonacid C, Campos C, Morena D, Benavent M, González-de-Olano D, Rodríguez JM. Izquierdo JL, et al. Among authors: almonacid c. J Investig Allergol Clin Immunol. 2021 Nov 11:0. doi: 10.18176/jiaci.0765. Online ahead of print. J Investig Allergol Clin Immunol. 2021. PMID: 34779775 Free article.
[Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19].
Almonacid C, Blanco-Aparicio M, Domínguez-Ortega J, Giner J, Molina J, Plaza V; en representación del grupo de trabajo COMETA. Almonacid C, et al. Arch Bronconeumol. 2021 Jan;57:13-14. doi: 10.1016/j.arbres.2020.10.005. Epub 2020 Oct 22. Arch Bronconeumol. 2021. PMID: 34629633 Free PMC article. Spanish. No abstract available.
Impact of Blood Eosinophil Variability in Asthma: A Real-Life Population Study.
Toledo-Pons N, van Boven JFM, Muncunill J, Millán A, Román-Rodriguez M, López-Andrade B, Almonacid C, Velasco Álvarez D, Kocks JWH, Cosio BG. Toledo-Pons N, et al. Among authors: almonacid c. Ann Am Thorac Soc. 2021 Sep 17. doi: 10.1513/AnnalsATS.202103-409OC. Online ahead of print. Ann Am Thorac Soc. 2021. PMID: 34534050
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score.
Pérez de Llano L, Dávila I, Martínez-Moragón E, Domínguez-Ortega J, Almonacid C, Colás C, García-Rivero JL, Carmona L, García de Yébenes MJ, Cosío BG; FEOS Study Group. Pérez de Llano L, et al. Among authors: almonacid c. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2725-2731. doi: 10.1016/j.jaip.2021.01.033. Epub 2021 Feb 4. J Allergy Clin Immunol Pract. 2021. PMID: 33549843
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
The impact of COVID-19 on patients with asthma.
Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, Lumbreras S, Soriano JB. Izquierdo JL, et al. Among authors: almonacid c. Eur Respir J. 2021 Mar 4;57(3):2003142. doi: 10.1183/13993003.03142-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33154029 Free PMC article.
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
Monreal E, Sainz de la Maza S, Natera-Villalba E, Beltrán-Corbellini Á, Rodríguez-Jorge F, Fernández-Velasco JI, Walo-Delgado P, Muriel A, Zamora J, Alonso-Canovas A, Fortún J, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. Monreal E, et al. Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):761-769. doi: 10.1007/s10096-020-04078-1. Epub 2020 Oct 20. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33083917 Free PMC article.
24 results